PAVIOUR PHARMACEUTICALS PVT LTD

During FY 20-21, New Delhi-based Paviour Pharmaceuticals witnessed a revenue generation of Rs 51 crore in the biopharma space, showing a growth of 17 per cent in comparison to the revenue generated during FY 19-20 at Rs 44 crore. The company was incorporated in 1998 with the objective of importing, marketing and distribution of various pharmaceutical specialty products which are not indigenously produced. The company has entered into marketing agreements with Biotest PharmaGermany, for marketing their pharmaceuticals in India and Nepal, and with Chiesi Farmaceutici SpA, Italy for marketing products in India and Bangladesh.